Enzyme replacement therapy (ERT) is a treatment where replacement enzymes are utilized for patients who suffer from rare and complex conditions...
In the past 18 months, perhaps no advice to prevent the spread of COVID-19 has been more widely promoted and easier to implement than the act of...
As physicians have expressed with increasingly louder volume in the last decade, one of their primary sources of frustration continues to be the prior...
November is National Family Caregivers Month. This month serves to appreciate the role of family caregivers, address the issues they face, and further...
Maintaining, Monitoring, and Measuring a Smooth Patient Journey The journey of a rare disease patient is not an easy one from the start, frequently...
Orsini Specialty Pharmacy, the leading independent specialty pharmacy focused on rare diseases and gene therapies, announced today that Sanofi has...
For more than 50 years, newborn screening for rare and congenital conditions has been part of healthcare in the United States. What began as a single...
Duchenne muscular dystrophy (DMD) is a genetic, progressive form of muscular dystrophy that occurs primarily in males. It is caused by genetic changes...
From filling out an insurance form to interpreting nutrition labels, a patient's understanding of what they're reading and ability to use that...
Orsini is a leading independent national specialty pharmacy accredited by ACHC, JCAHO, URAC, and VIPPS. The services we provide allow patients, physicians, payors, and manufacturers to improve care, simplify processes, and achieve better outcomes.
Orsini Specialty Pharmacy Selected as part of the Limited Specialty Pharmacy Network For VYJUVEK™
The Importance of Payor Credentialing When Selecting a Specialty Pharmacy Partner
Why You Need a Limited Distribution Network for Rare Disease Drugs
The 3 Distribution Models to Choose for a Specialty Drug Launch
Rare Disease Day: In Loving Memory of Tommy